HPV testing for cervical cancer screening in Mozambique: challenges and recommendations
Journal of Global Health Reports · 13.02.2022 · 6
DOI: 10.29392/001c.32432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health Reports, online erschienen am 13.02.2022. Verfasst von Cristina M. de Oliveira und 15 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cervical cancer is the fourth most common cancer affecting women worldwide and is the leading cause of cancer and related deaths among women in Mozambique. The World Health Organization (WHO) recommends screening with human papillomavirus (HPV) testing, but it has not yet been implemented in many low- and middle-income countries (LMICs). We conducted a cervical cancer screening study in Mozambique using the careHPV test (QIAGEN, Germantown, MD, USA). This study aimed to describe our experience with HPV testing for cervical cancer screening in Maputo, Mozambique, including challenges and lessons learned.
Methods
We conducted a cervical cancer screening pilot demonstration project at the General Hospital of Mavalane in Maputo, Mozambique, from April 2018 to September 2019, using primary HPV testing with careHPV. We performed the direct observations and discussions with participating laboratory experts, technicians, nurses and physicians from Mozambique, Brazil and the United States.
Results
HPV testing was successfully implemented. The main challenges we experienced were inadequately equipped laboratory facilities, a lack of laboratory and clinical staff expertise, and difficulties procuring equipment, tests and laboratory supplies. These challenges were overcome by increasing the budget to better equip the laboratory, building relationships with procurement and importation specialists and training sessions for laboratory personnel and medical providers.
Conclusions
Our findings suggest that primary HPV testing is achievable in Mozambique. Several challenges were identified and are being addressed for a successful scale-up.
Zitieren
APA
Oliveira, C. M. D., Salcedo, M. M. P., Monteiro, E., Mariano, A., Verdinho, M. J. C., Julião, R. D. A. M., Kundrod, K., Smith, C., Carns, J., Andrade, V., Baker, E., Phoolcharoen, N., Richards-Kortum, R. R., Fregnani, J. H. T. G., Schmeler, K. M., & Lorenzoni, C. (2022). HPV testing for cervical cancer screening in Mozambique: challenges and recommendations. Journal of Global Health Reports, 6. https://doi.org/10.29392/001c.32432
Vancouver
Oliveira CMD, Salcedo MMP, Monteiro E, Mariano A, Verdinho MJC, Julião RDAM, et al. HPV testing for cervical cancer screening in Mozambique: challenges and recommendations. Journal of Global Health Reports. 2022;6. doi:10.29392/001c.32432
BibTeX
@article{Oliveira2022,
author = {Oliveira, Cristina M. de and Salcedo, Mila M. P. and Monteiro, Eliane and Mariano, Arlete and Verdinho, Mario J. C. and Julião, Reginaldo de Alice M and Kundrod, Kathryn and Smith, Chelsey and Carns, Jennifer and Andrade, Viviane and Baker, Ellen and Phoolcharoen, Natacha and Richards-Kortum, Rebecca R. and Fregnani, José Humberto T. G. and Schmeler, Kathleen M. and Lorenzoni, Cesaltina},
title = {HPV testing for cervical cancer screening in Mozambique: challenges and recommendations},
journal = {Journal of Global Health Reports},
year = {2022},
volume = {6},
doi = {10.29392/001c.32432}
}
EUVIMED